Clinical Study Results
How has this study helped patients and researchers?
This study helped researchers learn more about using dapagliflozin and saxagliptin to treat people
who have type 2 diabetes and kidney damage.
Researchers look at the results of many studies to decide which treatments work best and are
safest. This summary shows only the main results from this one study. Other studies may provide
new information or different results.
Further clinical studies with dapagliflozin and saxagliptin taken together in patients who have kidney
damage are not planned. A large clinical study with dapagliflozin in patients who have kidney
damage is ongoing.
9